June 30, 202624 min read0 comments

Jamie

Head Cultivator

If you live with migraines, fibromyalgia, or an unpredictable gut, you've probably been told your tests look "normal" while your body feels anything but. One leading theory — still being tested, not proven — says your body's own cannabis-like chemicals might be running low. This article walks through what that idea actually means, what the evidence shows, and what you can do about it without buying into hype.

What Is the Endocannabinoid System — and Why Does It Matter? #

Your endocannabinoid system (ECS) is a built-in network that helps keep pain, mood, sleep, and gut function in balance — like a thermostat for your whole body. You have it whether or not you ever use cannabis. When it works well, your body makes its own cannabis-like chemicals and sends them to receptors (tiny docking sites) spread through your brain, nerves, immune cells, and gut.

Think of the ECS as your body's internal dimmer switch. Too much pain? It tries to turn it down. Too much stress? It tries to calm the alarm. Too much gut activity? It tries to slow things to a steady pace. For a full walkthrough of how this network works, see our endocannabinoid system deep dive.

The Three Main Pieces #

Piece	Plain-English Name	What It Does
Endocannabinoids	Your body's own "weed-like" chemicals	Carry messages between cells to restore balance
Receptors (CB1 and CB2)	Docking sites on cells	Receive the signal and trigger a response
Enzymes (FAAH, MAGL)	Cleanup crew	Break down endocannabinoids when the job is done

The two best-known endocannabinoids are:

Anandamide (AEA) — often called the "bliss molecule." It binds mainly to CB1 receptors in the brain and nerves. It helps with pain, mood, and stress relief. We cover it in depth in your body makes its own weed.
2-AG (2-arachidonoylglycerol) — works at both CB1 and CB2 receptors. It plays a big role in immune signaling and inflammation control.

Your ECS is not a single organ. It is a signaling system — more like your nervous system or hormone system than a body part you can point to on an X-ray. That is one reason it is hard to study and even harder to "diagnose" when something might be off.

Why Balance Matters #

When endocannabinoid tone — the overall activity level of this system — stays in a healthy range, your body can respond to stress without overreacting. When tone drops too low or stays dysregulated for too long, some researchers think certain chronic conditions become more likely.

That last sentence is important: "some researchers think." The idea that low ECS tone drives illness is a theory under active study, not a settled medical fact. But understanding the ECS first makes the deficiency theory much easier to follow.

What Is Clinical Endocannabinoid Deficiency (CED)? #

Clinical Endocannabinoid Deficiency (CED) — also called CECD — is a leading theory that says some chronic illnesses may stem from the body not making or using enough of its own endocannabinoids. It is not an official medical diagnosis. No doctor can hand you a CED lab result today. It is a research framework that helps explain why certain hard-to-treat conditions often show up together.

Dr. Ethan Russo, a neurologist and cannabis researcher, first laid out this idea in a 2004 review published in Neuro Endocrinology Letters. He updated and expanded it in a 2016 review in Cannabis and Cannabinoid Research, where he argued that growing evidence supports the theory — especially for migraine, fibromyalgia, and irritable bowel syndrome (IBS).

Who Proposed the CED Theory? #

Dr. Ethan Russo proposed the CED theory after decades of studying how cannabis compounds interact with the human nervous system. Russo is not a random internet theorist. He is a board-certified neurologist who has published extensively on cannabinoid pharmacology and the endocannabinoid system.

His core argument in the 2016 reconsideration paper goes like this:

The endocannabinoid system regulates pain, mood, sleep, digestion, and immune responses.
Several chronic conditions share a pattern of hyperalgesia — pain that feels out of proportion to any visible injury.
Those same conditions often co-occur in the same person (migraine plus IBS plus fibromyalgia, for example).
Some patients with these conditions show lower anandamide levels in cerebrospinal fluid (the fluid around the brain and spine) or other signs of ECS underactivity.
Cannabis and cannabinoid medicines sometimes help when other treatments fail — which fits the idea that the system needed a boost.

Russo himself has been careful to frame CED as a hypothesis worth testing, not a proven disease category. That honesty matters. Many wellness blogs skip it. We will not.

What Would "Running Low" Actually Mean? #

"Running low" in the CED theory does not mean your ECS is empty. It means the system's overall tone may be chronically below what your body needs to keep pain, mood, and gut function stable.

Low tone could happen in several ways:

Possible Problem	What Goes Wrong	Plain-English Effect
Low production	Body makes too little anandamide or 2-AG	Less natural pain and mood buffering
Overactive breakdown	Enzymes like FAAH destroy endocannabinoids too fast	Signals get cut short before they help
Receptor issues	CB1 or CB2 receptors are less responsive	Same amount of chemical, weaker effect
Transport problems	Endocannabinoids do not reach the right cells	Messages do not arrive where needed

None of these problems show up on a standard blood panel. Endocannabinoids are made on demand, used locally, and broken down within seconds or minutes. That is why measuring them is so hard — and why the CED theory remains open for debate.

Which Conditions Are Linked to the CED Theory? #

The CED theory focuses on a "triad" of conditions — migraine, fibromyalgia, and IBS — that often overlap and resist standard treatment. Russo chose these three because they share central sensitization (a nervous system stuck on high alert), hyperalgesia, and high rates of anxiety and depression. Other conditions — PTSD, motion sickness, and some treatment-resistant pain syndromes — have been suggested as possible extensions, but the evidence is thinner.

This is not a claim that every person with these diagnoses has CED. It is a research lens: could ECS dysfunction be one shared thread?

Migraine and Headache Disorders #

Migraine patients — especially those with chronic migraine — have shown lower anandamide levels in cerebrospinal fluid in multiple studies, which is one of the strongest pieces of evidence for the CED theory.

A landmark study in Neuropsychopharmacology found that people with chronic migraine had significantly lower CSF anandamide compared to healthy controls and even episodic migraine patients (Nature Neuropsychopharmacology study). Lower anandamide in the fluid bathing the brain suggests the pain-control system may not be keeping up.

Other migraine-ECS links researchers have noted:

Migraineurs often have comorbid IBS and fibromyalgia at rates well above the general population — the same triad CED predicts.
Cannabinoid receptors are dense in brain regions involved in migraine pain pathways, including the trigeminovascular system.
Some patients report cannabis or CBD helps when triptans and NSAIDs fall short — though patient reports are not the same as clinical proof.

For a condition-by-condition look at cannabis and migraine specifically, see our cannabis for migraines guide.

Fibromyalgia and Widespread Pain #

Fibromyalgia involves widespread pain, fatigue, and sleep disruption — and the CED theory suggests low endocannabinoid tone may keep the pain alarm stuck in the "on" position.

Fibromyalgia is often described as a central sensitization syndrome. The nervous system amplifies pain signals even when tissues are not badly damaged. The ECS normally helps dampen those signals through CB1 receptors in the brain and spinal cord. If endocannabinoid tone is low, that dampening may fail.

In his 2016 review, Russo noted that fibromyalgia patients frequently overlap with migraine and IBS — again matching the triad pattern. Some small studies have found altered endocannabinoid levels or receptor function in fibromyalgia, but results are mixed and sample sizes are often small.

What we can say with confidence: fibromyalgia is real, it is hard to treat, and the ECS is a plausible — not proven — piece of the puzzle.

IBS and Gut Problems #

IBS involves cramping, bloating, and unpredictable bowel habits — and your gut has one of the highest concentrations of cannabinoid receptors in the body.

The ECS in the gut helps regulate:

Motility — how fast food moves through your intestines
Secretion — how much fluid your gut produces
Visceral pain — pain coming from internal organs, not skin or muscle
Inflammation — immune activity in the gut lining

CB1 and CB2 receptors sit throughout the digestive tract. When endocannabinoid signaling is weak, the gut may swing between sluggish and overactive — a pattern many IBS patients know well. A 2018 Frontiers in Pharmacology review described the gut ECS as a key modulator of intestinal function and a promising target for IBS research.

Again: IBS has many causes. CED is one theory about a shared mechanism, not the whole story.

What Does the Research Actually Show? #

The CED theory has real supporting data — especially for migraine — but it has not crossed the line into proven medical fact. No major medical body recognizes CED as a diagnosis. No standardized test exists. What we have is a growing pile of clues that point in the same direction, plus honest gaps that skeptics are right to flag.

Evidence That Supports the Theory #

The strongest CED evidence comes from migraine CSF studies, condition overlap patterns, and genetic links to ECS enzymes — not from one single knockout trial.

Evidence Type	What Researchers Found	Why It Matters
CSF anandamide in migraine	Chronic migraine patients show lower anandamide in cerebrospinal fluid	Suggests a brain-level deficiency in a key pain-buffering chemical (Nature study)
Triad overlap	Migraine, fibromyalgia, and IBS co-occur at high rates in the same patients	Matches Russo's predicted cluster (Russo 2016 review)
FAAH gene variants	Some migraine-related genetic studies link FAAH (the enzyme that breaks down anandamide) to headache risk	Supports the "overactive breakdown" model (PMC migraine genetics review)
Cannabinoid treatment responses	Some patients with treatment-resistant migraine, fibro, or IBS report relief from cannabis or cannabinoid medicines	Fits the "system needed support" idea — but placebo and individual variation complicate the picture
Recent reviews (2023–2026)	Updated reviews continue to describe CED as an emerging paradigm with the strongest data in the migraine-fibro-IBS cluster	Shows active research interest, not a dead-end idea (Frontiers in Neuroscience 2023 review)

A 2026 PMC review further examined endocannabinoid dysregulation across neurological conditions, adding to the body of work that treats ECS tone as a meaningful variable — even while stopping short of calling CED a confirmed syndrome.

Evidence That Pushes Back #

Critics of the CED theory point to measurement problems, mixed blood-test results, and the lack of diagnostic criteria — and those criticisms are valid.

Here is where the theory gets shaky:

No official diagnosis. CED is not in the ICD (International Classification of Diseases) or DSM. You cannot bill insurance for it. No clinical guideline tells doctors how to test or treat it.
Hard to measure endocannabinoids. Anandamide and 2-AG are made on demand, act locally, and break down in minutes. Blood levels often do not reflect what is happening in the brain or gut. A normal serum reading does not rule out a regional deficiency.
Mixed plasma results. Some studies find lower circulating endocannabinoids in patients; others find no difference. Episodic migraine patients, for example, do not always show the same CSF pattern as chronic migraine patients.
Correlation is not causation. Lower anandamide might be a result of chronic pain and stress, not the cause. Long-term pain itself can dysregulate many systems.
Cannabis helps ≠ CED confirmed. The fact that some patients feel better with cannabis could mean many things — including placebo effect, anti-inflammatory action, or simple pain relief — not necessarily that they had a measurable deficiency.
Overextension risk. Some wellness marketers apply CED to almost every symptom — fatigue, brain fog, anxiety, weight gain. That goes well beyond what Russo's original papers support.

The honest summary: CED is an interesting, evidence-tending theory — not a diagnosis you should self-assign. If someone tells you that you "definitely have endocannabinoid deficiency," they are overselling the science.

How Can You Support Endocannabinoid Tone Naturally? #

You can support your endocannabinoid system through regular movement, solid sleep, stress management, and certain foods — without cannabis. These habits will not "cure" CED (which is not a confirmed diagnosis anyway), but they are low-risk ways to help your body's balance system work better. Think of them as thermostat maintenance, not a magic fix.

Exercise and Movement #

Enjoyable, moderate exercise raises anandamide levels — the same chemical implicated in the CED theory — which may explain why movement helps mood and pain for so many people.

The "runner's high" was once blamed entirely on endorphins. Research now shows endocannabinoids — especially anandamide — play a major role. A 2018 Frontiers in Pharmacology review described exercise as one of the most reliable ways to boost ECS tone.

What works best:

Activity	ECS Effect	Practical Tip
Running or brisk walking	Raises blood anandamide	20–30 minutes at a comfortable pace
Yoga and Tai Chi	Boosts endocannabinoids through movement plus breath work	Even 15 minutes counts
Swimming	Low-impact, good for fibromyalgia-friendly movement	Warm pool may ease joint pain
Strength training (moderate)	Supports overall nervous system health	Avoid extreme overtraining

Important caveat: Hard, stressful overtraining can actually reduce CB1 signaling and deplete ECS tone. The key word is ** enjoyable**. If your workout feels like punishment, it may not help your endocannabinoid system the way a walk in the sun will.

Sleep, Stress, and Daily Habits #

Poor sleep and chronic stress drain endocannabinoid tone — while rest and relaxation help rebuild it.

Your ECS and your stress system (the HPA axis) talk to each other constantly. When stress stays high for months or years:

Cortisol (your main stress hormone) can disrupt endocannabinoid signaling
Sleep loss reduces CB1 receptor sensitivity in some animal studies
Anxiety and pain feed each other in a loop that may further lower tone

Daily habits that support ECS tone without cannabis:

Protect 7–9 hours of sleep — same bedtime, dark room, no screens before bed
Practice slow breathing — 4-7-8 breathing or box breathing for 5 minutes
Spend time outdoors — morning light helps circadian rhythm and mood
Try cold exposure (brief) — some research suggests cold showers or cold plunges may stimulate endocannabinoid release, though evidence is early
Maintain social connection — isolation and chronic loneliness correlate with lower endocannabinoid activity in some studies

None of these replace medical care for migraine, fibromyalgia, or IBS. They are baseline wellness habits that happen to align with ECS science.

Food Choices That May Help #

A diet rich in omega-3 fats and plant compounds called flavonoids may give your body the raw materials to make endocannabinoids.

Endocannabinoids are built from arachidonic acid and other fatty acids. Your body needs healthy fats to produce them.

Food / Nutrient	Why It May Help	Examples
Omega-3 fatty acids	Building blocks for endocannabinoid production	Salmon, sardines, walnuts, flaxseed
Flavonoids	Plant compounds that may slow endocannabinoid breakdown	Dark chocolate (70%+), berries, green tea
Extra-virgin olive oil	Healthy fat source; Mediterranean diet links to lower inflammation	Drizzle on salads, cook at low heat
Fermented foods	Gut health supports the gut ECS	Yogurt, kimchi, sauerkraut (if tolerated)

Foods that may not help — or may hurt ECS tone:

Heavy alcohol use (can disrupt CB1 receptor function)
Ultra-processed foods high in inflammatory fats
Extreme calorie restriction (can stress the system)

A PMC review on dietary influences on the ECS noted that long-chain omega-3 polyunsaturated fatty acids may increase endocannabinoid production and reduce inflammatory signaling. This is not a diet prescription — it is a reason to eat real food when you can.

Where Does Cannabis Fit — and What Don't We Know Yet? #

Cannabis may help some people with migraine, fibromyalgia, or IBS by supplementing the same receptor system the CED theory says could be underactive — but that does not prove the theory, and cannabis is not a CED treatment approved by any medical authority.

Plant cannabinoids like THC and CBD interact with the same CB1 and CB2 receptors your endocannabinoids use. THC binds strongly to CB1 (which is why it affects pain and mood). CBD works differently — it does not bind CB1 directly but may slow the breakdown of anandamide by inhibiting the FAAH enzyme.

Why Cannabis Gets Connected to CED #

The logic chain looks like this:

CED theory says some patients may have low endocannabinoid tone.
Cannabis provides external cannabinoids that activate the same receptors.
Some patients with treatment-resistant conditions report relief.
Therefore, cannabis might be "replacing" what the body lacks.

That chain is plausible but incomplete. Here is what we do not know:

Open Question	Why It Matters
Does cannabis restore tone or mask symptoms?	Pain relief does not prove the underlying deficiency existed
What dose and ratio works?	THC, CBD, terpenes, and delivery method all change the effect
Who responds and who does not?	Migraine patients, for example, can have wildly different reactions — some get relief, others trigger a headache
Long-term effects on the ECS	Chronic THC use may downregulate CB1 receptors (tolerance), potentially lowering natural tone over time
Drug interactions	Cannabis can interact with migraine meds, blood thinners, and other prescriptions

For CB1 and CB2 receptor basics — how plant cannabinoids actually dock — see CB1 and CB2 receptors explained.

What Responsible Use Looks Like #

If you and your doctor are exploring cannabis for a chronic condition linked to the CED theory:

Start low and go slow — especially with THC
Track your symptoms — note what helps, what triggers, and at what dose
Tell your doctor — even in legal states, your care team needs the full picture
Do not stop prescribed meds without guidance — cannabis is a complement to discuss, not a swap to make alone
Choose clean products — pesticides and contaminants matter more when you are using cannabis for health, not just recreation

At Divine Toke, we grow sun-grown organic flower in Michigan without pesticides. We will not tell you a specific strain "treats CED" — that claim is not supported. We will say that if you and your doctor decide cannabis fits your plan, clean input matters. What goes in the plant goes in you.

What Research Still Needs to Answer #

Future studies that would strengthen or weaken the CED theory include:

Larger CSF anandamide studies across all three triad conditions
Longitudinal tracking — do endocannabinoid levels predict who gets chronic migraine?
Randomized trials of FAAH inhibitors or selective cannabinoid medicines
Genetic screening for ECS-related variants in treatment-resistant patients

Until that work lands, cannabis remains a personal wellness tool some patients find useful — not a confirmed CED cure.

What Should a Skeptic Keep in Mind? #

A healthy skepticism about CED is warranted — the theory is real science, but it is not yet real medicine. If you have heard bold claims that "everyone with chronic pain has endocannabinoid deficiency" or that cannabis is the only fix, those claims outrun the evidence.

Red Flags to Watch For #

Claim	Reality Check
"You definitely have CED"	No validated test exists. No doctor can confirm this today.
"Cannabis cures migraine/fibro/IBS"	Some patients improve. Many do not. Cannabis is not FDA-approved for these conditions.
"CBD gummies fix your ECS"	Most OTC CBD products are poorly regulated. Dose and quality vary wildly.
"CED explains all chronic illness"	Russo's original work focused on a specific triad. Broad application is speculation.
"Big Pharma is hiding CED"	The theory is published in peer-reviewed journals. The gap is evidence, not conspiracy.

What Good-Faith Believers Get Right #

Skepticism should not dismiss the whole idea. These points hold up:

The endocannabinoid system is real, well-documented biology — not wellness fiction.
Migraine CSF anandamide data is published in reputable journals, not blog posts.
Condition overlap (migraine + IBS + fibro) is documented in epidemiology, not invented for marketing.
Some cannabinoid medicines (nabilone, dronabinol) are FDA-approved for other conditions, proving the receptor system is a legitimate drug target.
Lifestyle factors that boost ECS tone (exercise, sleep, omega-3s) are low-risk and broadly health-positive regardless of CED.

The Balanced Take #

CED is a leading theory researchers are still testing — not a label to put on yourself after a quiz or a podcast.

If you have migraines, fibromyalgia, or IBS:

Work with qualified healthcare providers on proven treatments first.
Treat ECS-supporting habits (movement, sleep, nutrition) as general wellness — they help almost everyone.
If you explore cannabis, do it with eyes open about the evidence gaps.
Be wary of anyone selling a simple answer to a complex problem.

That is the honest middle ground — and it is where we think good science communication should live.

Frequently Asked Questions #

What is endocannabinoid deficiency? #

Endocannabinoid deficiency is a theory — not a confirmed diagnosis — that suggests some chronic conditions may involve the body making or using too little of its own cannabis-like chemicals. Dr. Ethan Russo proposed the idea in a 2004 review and expanded it in 2016. The theory focuses on low levels of anandamide and 2-AG, the two main endocannabinoids your body produces naturally.

Is clinical endocannabinoid deficiency a real diagnosis? #

No. CED is not recognized as an official medical diagnosis by any major medical organization. There are no ICD codes, no standard lab tests, and no clinical guidelines for treating it. It remains a research hypothesis that some scientists find promising — especially for migraine, fibromyalgia, and IBS — but it has not been proven as a standalone disease.

What are the symptoms of endocannabinoid deficiency? #

There is no validated symptom checklist for CED because it is not a confirmed condition. The theory links it to symptoms seen in the migraine-fibromyalgia-IBS cluster: chronic pain, heightened pain sensitivity (hyperalgesia), digestive problems, sleep disruption, anxiety, and depression. These symptoms have many other causes, so they cannot confirm CED on their own.

Can a doctor test for endocannabinoid deficiency? #

Not in any standard clinical way. Endocannabinoids break down within minutes, and blood levels often do not reflect activity in the brain or gut. Some research studies measure anandamide in cerebrospinal fluid, but that requires a spinal tap — a research procedure, not a routine clinic test. No at-home test or blood panel can diagnose CED today.

Does low anandamide cause migraines? #

Lower anandamide in cerebrospinal fluid has been found in chronic migraine patients, but that does not prove low anandamide causes migraines. A Neuropsychopharmacology study found significantly reduced CSF anandamide in chronic migraine. Whether the low level is a cause, a consequence of chronic pain, or both is still being studied.

Is fibromyalgia linked to the endocannabinoid system? #

Fibromyalgia may involve endocannabinoid dysregulation, but the link is not confirmed. Fibromyalgia features central sensitization — a nervous system that amplifies pain — and the ECS normally helps dampen those signals through CB1 receptors. Some studies show altered endocannabinoid levels in fibromyalgia patients, but results are mixed and sample sizes are small.

Can diet boost your endocannabinoid system? #

A diet rich in omega-3 fatty acids and plant flavonoids may support endocannabinoid production, according to early research. A PMC dietary review noted that long-chain omega-3 PUFAs can influence endocannabinoid levels. Good sources include fatty fish, walnuts, flaxseed, olive oil, berries, and dark chocolate. Diet alone is unlikely to resolve chronic pain conditions.

Does exercise increase anandamide? #

Yes — moderate, enjoyable exercise reliably raises anandamide levels in the blood. A 2018 Frontiers in Pharmacology review identified exercise as one of the strongest natural ECS boosters. Running, yoga, swimming, and Tai Chi have all been linked to higher endocannabinoid activity. Overtraining, however, may have the opposite effect.

Can cannabis treat endocannabinoid deficiency? #

Cannabis is not an approved treatment for CED because CED itself is not a recognized diagnosis. Some patients with migraine, fibromyalgia, or IBS report symptom relief from cannabis, which fits the theory that external cannabinoids may support an underactive ECS. But relief in some patients does not prove the deficiency existed or that cannabis is the right long-term answer for everyone.

Who is Dr. Ethan Russo and what did he propose? #

Dr. Ethan Russo is a neurologist and cannabinoid researcher who proposed the Clinical Endocannabinoid Deficiency theory in 2004. His original paper suggested that deficient endocannabinoid activity could underlie migraine, fibromyalgia, and IBS. His 2016 update reviewed new evidence and argued the theory was gaining support — while acknowledging that more research was needed.

Is endocannabinoid deficiency the same as ECS dysfunction? #

They are related ideas but not identical. "ECS dysfunction" is a broad term for any problem with endocannabinoid signaling — production, receptors, or breakdown. CED specifically proposes that a deficiency in endocannabinoid levels or tone drives certain chronic conditions. ECS dysfunction could also mean overactivity, not just low tone.

Should I try cannabis if I think I have CED? #

Talk to your doctor first — and know that self-diagnosing CED is not supported by current medical science. If you and your provider decide cannabis is worth exploring for migraine, fibromyalgia, or IBS symptoms, start with a low dose, track your response, and keep up with proven treatments. Cannabis helps some people and worsens symptoms for others — especially high-THC products in migraine-prone individuals.

Closing Thoughts #

If you have spent years with migraines that will not quit, fibromyalgia pain that scans cannot explain, or a gut that never seems stable, the CED theory offers a possible "why" — not a confirmed answer. Your endocannabinoid system is real. The overlap between these conditions is real. The anandamide data in migraine research is real. But the jump from "interesting theory" to "you have a deficiency" is a jump science has not made yet.

What you can do today is practical: move your body in ways you enjoy, protect your sleep, eat foods that give your cells good building blocks, and work with a doctor who takes your symptoms seriously. If cannabis enters the conversation, approach it as one tool in a larger plan — not a diagnosis-driven cure.

Want to go deeper on the system behind all of this? Start with our endocannabinoid system deep dive, learn how your body makes anandamide on its own, and read how cannabis fits into the migraine conversation specifically.

If you are curious to try clean, sun-grown organic flower as part of your wellness routine, we grow it right here in Michigan at Divine Toke — no pesticides, no shortcuts. Whatever path you choose, we hope this article gave you a clearer picture of what the science actually says.

This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before starting any new wellness routine.

Share

Endocannabinoid Deficiency: Is Your Body Running Low?